Citations

Clear

4610 citation(s) found for "Lu, Brian".

Cochlear Implant Outcomes between Patients with Sporadic and Neurofibromatosis Type 2–Associated Vestibular Schwannoma
Dornhoffer, James R. , Haller, Travis J. , Lohse, Christine M. , Driscoll, Colin L. W., Neff, Brian A., Saoji, Aniket A. , Link, Michael J. , Carlson, Matthew L. , Haller, Travis, Saoji, Aniket

Mayo Clinic

Otology & Neurotology | July 19, 2023 | Volume: 44 | Issue: 8 | Pages: 791-797

10.1097/mao.0000000000003963 | PMID 37464449 Get It

Objective Compare cochlear implant (CI) performance between patients with ipsilateral sporadic vestibular schwannoma (VS) and NF2-related schwannomatosis (NF2). Compare CI performance according to VS management modality. Study Design Historical cohort. Setting Tertiary academic center. Patients Forty-nine patients (52 ears) undergoing cochlear implantation in the setting of ipsilateral sporadic (n = 21) or NF2-associated VS (n = 28). Interventions CI ipsilateral to VS. Main Outcome Measures Auditory thresholds, consonant–nucleus–consonant (CNC) word scores, and AzBio sentences in quiet scores. Results Among all patients, median post-CI pure tone average was 28 dB HL (interquartile range [IQR], 21–38), CNC word score was 39% (IQR, 6–62), and AzBio sentences in quiet score was 60% (IQR, 11–83) at a median of 12.5 months postimplantation. Despite the NF2 cohort having larger tumors, when comparing patients with sporadic versus NF2-associated VS, there were no statistically significant differences in CNC word (49% [30–70] vs. 31% [0–52]) or AzBio sentences in quiet (66% [28–80] vs. 57% [5–83]) scores. Regardless of NF2 status, all patients managed with observation, and radiosurgery achieved open-set speech. In patients who underwent microsurgery, 6 (46%) of 13 with NF2 achieved open-set speech recognition compared with 4 (67%) of 6 with sporadic disease. Conclusion Select patients with VS achieve successful hearing rehabilitation with a CI. In this cohort, tumor management strategy significantly influenced CI performance, whereas differences in NF2 status exhibited less effect. Specifically, all patients managed with observation or radiosurgery achieved open-set speech perception, whereas approximately half of people with NF2-related VS and two-thirds of people with sporadic VS achieved this outcome after tumor microsurgery. When disease permits, observation and radiosurgery should be considered in patients who may later pursue a CI.
Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay
Coelho, Teresa , Grogan, Martha , Conceição, Isabel , Kristen, Arnt V. , Wixner, Jonas , González‐Moreno, Juan , Maurer, Mathew S. , García‐Pavía, Pablo , Tournev, Ivailo , González‐Costello, José , Cariou, Eve, Glass, Oliver, Chapman, Doug, Amass, Leslie, investigators, on behalf of the THAOS, Hüsing‐Kabar, Anna, Drachman, Brian, Sekijima, Yoshiki , Jeon, Eun‐Seok , Slosky, David, Hanna, Mazen , Freimer, Miriam , Muñoz-Beamud, Francisco, Mølgaard, Henning, Press, Rayomand , Cirami, Calogero Lino , Plana, Josep Maria Campistol, Inamo, Jocelyn , Quan, Dianna , Dori, Amir , Murali, Srinivas, Živković, Saša , Correia, Edileide de Barros , Nicolau, José Nativi, Tallaj, José , Fernández‐Torrón, Roberto , Polydefkis, Michael , Tauras, James M. , Ventura, Hector, Brunkhorst, Robert, Darstein, Felix , Marburger, Tessa, Mueller, Christopher R. , Cleemput, Johan Van , Parman, Yeşim , Sarswat, N., Warner, Alberta L. , Steidley, D. Eric , Ralph, Jeffrey , Cotts, William, Hoffman, James E. , Rugiero, Marcelo, Misawa, Sonoko , Muñoz-Blanco, José Luís , Dávila, Lucía Galán, Sadeh, Menachem , Luo, Jin, Kyriakides, Theodoros , Wang, Annabel , Dispenzieri, Angela , Conceição, Isabel , Garcia-Pavia, Pablo , Dispenzieri, Angela , Waddington‐Cruz, Márcia , Diemberger, Igor , Maurer, Mathew S , Planté‐Bordeneuve, Violaine , González-Duarte, Alejandra , investigators, on behalf of the THAOS, Barroso, Fábio , Ueda, Mitsuharu , Mazzeo, Anna Teresa , Gentile, Luca , Luigetti, Marco , Adams, David , Nienhuis, Hans L. A. , Emdin, Michele , Miller, Edward J. , Hummel, Scott L. , Witteles, Ronald , Shah, Sanjiv J , Lenihan, Daniel , Azevedo, Olga , Tan, Cheng‐Yin , Fine, Nowell Mark , Tschöpe, Carsten , Obici, Laura , BADELITA, Sorina Nicoleta , Gottlieb, Stephen S. , Oh, Jeeyoung , Mueller, Christopher, Salutto, Valeria , Chao, Chi‐Chao , Kaufmann, Horacio

Mayo Clinic

Amyloid | July 17, 2023 | Volume: 30 | Issue: 4 | Pages: 445-448

10.1080/13506129.2023.2229484 | PMID 37459334 Get It

Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories
Borate, Uma , Yang, Fei , Press, Richard D. , Ruppert, Amy S. , Caruthers, Sean, Zhao, Weiqiang , Vergilio, Jo‐Anne, Pavlick, Dean C. , Juckett, Luke, Norris, Brianna, Burd, Amy , Stein, Eytan M. , Patel, Prapti A. , Baer, Maria R. , Schiller, Gary J. , Blum, William , Kovacsovics, Tibor , Litzow, Mark R. , Foran, James M. , Heerema, Nyla A. , Rosenberg, Leonard, Marcus, Sonja, Yocum, Ashley O. , Stefanos, Mona , Byrd, John C. , Byrd, John C. , Press, Richard , Bucy, Taylor , Litzow, Mark R. , Druker, Brian J , Mims, Alice S , Byrd, John C , Jones, Dan M. , Stock, Wendy , Levine, Ross L.

Mayo Clinic

Blood Advances | July 17, 2023 | Volume: 7 | Issue: 20 | Pages: 6048-6054

10.1182/bloodadvances.2022009008 | PMID 37459200 Get It

AbstractNext-generation sequencing (NGS) to identify pathogenic mutations is an integral part of acute myeloid leukemia (AML) therapeutic decision-making. The concordance in identifying pathogenic mutations among different NGS platforms at different diagnostic laboratories has been studied in solid tumors but not in myeloid malignancies to date. To determine this interlaboratory concordance, we collected a total of 194 AML bone marrow or peripheral blood samples from newly diagnosed patients with AML enrolled in the Beat AML Master Trial (BAMT) at 2 academic institutions. We analyzed the diagnostic samples from patients with AML for the detection of pathogenic myeloid mutations in 8 genes (DNMT3A, FLT3, IDH1, IDH2, NPM1, TET2, TP53, and WT1) locally using the Hematologic Neoplasm Mutation Panel (50-gene myeloid indication filter) (site 1) or the GeneTrails Comprehensive Heme Panel (site 2) at the 2 institutions and compared them with the central results from the diagnostic laboratory for the BAMT, Foundation Medicine, Inc. The overall percent agreement was over 95% each in all 8 genes, with almost perfect agreement (κ > 0.906) in all but WT1, which had substantial agreement (κ = 0.848) when controlling for site. The minimal discrepancies were due to reporting variants of unknown significance (VUS) for the WT1 and TP53 genes. These results indicate that the various NGS methods used to analyze samples from patients with AML enrolled in the BAMT show high concordance, a reassuring finding given the wide use of NGS for therapeutic decision-making in AML.
Clinical characteristics and outcomes of pancreatic fungal infection in patients with necrotizing pancreatitis
Chesdachai, Supavit , Lahr, Brian D. , Vege, Santhi Swaroop , Vergidis, Paschalis , Vergidis, Paschalis , Chesdachai, Supavit , Yetmar, Zachary A.

Mayo Clinic

Medical Mycology | July 12, 2023 | Volume: 61 | Issue: 7 | Pages: No page available

10.1093/mmy/myad068 | PMID 37433581 Get It

Abstract Pancreatic fungal infection (PFI) in patients with necrotizing pancreatitis can lead to significant morbidity and mortality. The incidence of PFI has increased during the past decade. Our study aimed to provide contemporary observations on the clinical characteristics and outcomes of PFI in comparison to pancreatic bacterial infection and necrotizing pancreatitis without infection. We conducted a retrospective study of patients with necrotizing pancreatitis (acute necrotic collection or walled-off necrosis), who underwent pancreatic intervention (necrosectomy and/or drainage) and had tissue/fluid culture between 2005 and 2021. We excluded patients with pancreatic procedures prior to hospitalization. Multivariable logistic and Cox regression models were fitted for in-hospital and 1-year survival outcomes. A total of 225 patients with necrotizing pancreatitis were included. Pancreatic fluid and/or tissue was obtained from endoscopic necrosectomy and/or drainage (76.0%), CT-guided percutaneous aspiration (20.9%), or surgical necrosectomy (3.1%). Nearly half of the patients had PFI with or without concomitant bacterial infection (48.0%), while the remaining patients had either bacterial infection alone (31.1%) or no infection (20.9%). In multivariable analysis to assess the risk of PFI or bacterial infection alone, only previous pancreatitis was associated with an increased odds of PFI vs. no infection (OR 4.07, 95% CI 1.13-14.69, p = .032). Multivariable regression analyses revealed no significant differences in in-hospital outcomes or one-year survival between the 3 groups. Pancreatic fungal infection occurred in nearly half of necrotizing pancreatitis. Contrary to many of the previous reports, there was no significant difference in important clinical outcomes between the PFI group and each of the other two groups.
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Chiorean, E. Gabriela , Chiaro, Marco Del , Tempero, Margaret A. , Malafa, Mokenge P. , Benson, Al B. , Cardin, Dana B. , Christensen, Jared A. , Czito, Brian G. , Dillhoff, Mary , Donahue, Timothy R. , Hardacre, Jeffrey M., Klute, Kelsey , Ko, Andrew H. , LoConte, Noelle K. , Lowy, Andrew M. , Masood, Ashiq , Moravek, Cassadie, Nakakura, Eric K. , Narang, Amol , Nardo, Lorenzo , Obando, Jorge, Reddy, Sushanth , Reyngold, Marsha , Scaife, Courtney L. , Shen, Jeanne , Truty, Mark J. , Vollmer, Charles M., Wolff, Robert A. , Wolpin, Brian M. , McCullough, Beth, Lubin, Senem, Darlow, Susan, Cardin, Dana B , LoConte, Noelle , Chung, Vincent , Dotan, Efrat , Fountzilas, Christos , Glazer, Evan S. , Hawkins, William G , Kunstman, John W. , Polanco, Patricio Marcelo

Mayo Clinic

Journal of the National Comprehensive Cancer Network | July 11, 2023 | Volume: 21 | Issue: 7 | Pages: 753-782

10.6004/jnccn.2023.0034 | PMID 37433437 Get It

Ampullary cancers refer to tumors originating from the ampulla of Vater (the ampulla, the intraduodenal portion of the bile duct, and the intraduodenal portion of the pancreatic duct), while periampullary cancers may arise from locations encompassing the head of the pancreas, distal bile duct, duodenum, or ampulla of Vater. Ampullary cancers are rare gastrointestinal malignancies, and prognosis varies greatly based on factors such as patient age, TNM classification, differentiation grade, and treatment modality received. Systemic therapy is used in all stages of ampullary cancer, including neoadjuvant therapy, adjuvant therapy, and first-line or subsequent-line therapy for locally advanced, metastatic, and recurrent disease. Radiation therapy may be used in localized ampullary cancer, sometimes in combination with chemotherapy, but there is no high-level evidence to support its utility. Select tumors may be treated surgically. This article describes NCCN recommendations regarding management of ampullary adenocarcinoma.
Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum
Zhang, Liwen , Flagan, Taru , Häkkinen, Suvi , Chu, Stephanie A. , Brown, Jesse A. , Lee, Alex J. , Mandelli, Maria Luisa , Gorno‐Tempini, Maria Luisa , Sturm, Virginia E. , Yokoyama, Jennifer S. , Domoto‐Reilly, Kimiko , Geschwind, Daniel H. , Ghoshal, Nupur , Graff‐Radford, Neill R. , Huey, Edward D. , Kantarci, Kejal , Lago, Argentina Lario , Mackenzie, Ian R. , Mendez, Mario F. , Onyike, Chiadi U. , Ramos, Eliana Marisa , Roberson, Erik D. , Weıntraub, Sandra , Forsberg, Leah K. , Heuer, Hilary W. , Boxer, Adam L. , Rosen, Howard J. , Lee, Suzee E. , Consortia, the ARTFL/LEFFTDS/ALLFTD, Kantarci, Kejal , Tartaglia, Maria Carmela , Lee, Suzee E , Roberson, Erik , Yokoyama, Jennifer , Domoto-Reilly, Kimiko , Pasquini, Lorenzo , Appleby, Brian S. , Cobigo, Yann , Dickerson, Bradford Clark , Grossman, Murray , Hsiung, Ging‐Yuek Robin , Litvan, Irene , Toga, Arthur W. , Wszołek, Zbigniew K. , Boeve, Bradley F. , Miller, Bruce L. , Seeley, William W. , Consortia, the ARTFL/LEFFTDS/ALLFTD

Mayo Clinic

Annals of Neurology | July 11, 2023 | Volume: 94 | Issue: 4 | Pages: 632-646

10.1002/ana.26738 | PMID 37431188 Get It

ObjectiveMicrotubule‐associated protein tau (MAPT) mutations cause frontotemporal lobar degeneration, and novel biomarkers are urgently needed for early disease detection. We used task‐free functional magnetic resonance imaging (fMRI) mapping, a promising biomarker, to analyze network connectivity in symptomatic and presymptomatic MAPT mutation carriers.MethodsWe compared cross‐sectional fMRI data between 17 symptomatic and 39 presymptomatic carriers and 81 controls with (1) seed‐based analyses to examine connectivity within networks associated with the 4 most common MAPT‐associated clinical syndromes (ie, salience, corticobasal syndrome, progressive supranuclear palsy syndrome, and default mode networks) and (2) whole‐brain connectivity analyses. We applied K‐means clustering to explore connectivity heterogeneity in presymptomatic carriers at baseline. Neuropsychological measures, plasma neurofilament light chain, and gray matter volume were compared at baseline and longitudinally between the presymptomatic subgroups defined by their baseline whole‐brain connectivity profiles.ResultsSymptomatic and presymptomatic carriers had connectivity disruptions within MAPT‐syndromic networks. Compared to controls, presymptomatic carriers showed regions of connectivity alterations with age. Two presymptomatic subgroups were identified by clustering analysis, exhibiting predominantly either whole‐brain hypoconnectivity or hyperconnectivity at baseline. At baseline, these two presymptomatic subgroups did not differ in neuropsychological measures, although the hypoconnectivity subgroup had greater plasma neurofilament light chain levels than controls. Longitudinally, both subgroups showed visual memory decline (vs controls), yet the subgroup with baseline hypoconnectivity also had worsening verbal memory and neuropsychiatric symptoms, and extensive bilateral mesial temporal gray matter decline.InterpretationNetwork connectivity alterations arise as early as the presymptomatic phase. Future studies will determine whether presymptomatic carriers' baseline connectivity profiles predict symptomatic conversion. ANN NEUROL 2023;94:632–646
Factors Associated With Improved Pediatric Resuscitative Care in General Emergency Departments
Auerbach, Marc , Whitfill, Travis , Montgomery, Erin , Leung, James , Kessler, David , Gross, Isabel T. , Walsh, Barbara , Hamilton, Melinda, Gawel, Marcie, Kant, Shruti, Janofsky, Stephen , Brown, Linda , Walls, Theresa A. , Alletag, Michelle, Sessa, Anna , Arteaga, Grace M. , Keilman, Ashley , Ittersum, Wendy Van, Rutman, Maia S. , Zaveri, Pavan , Good, Grace , Schoen, Jessica C. , Lavoie, Meghan B., Mannenbach, Mark S., Bigham, Ladonna, Rutledge, Chrystal , Okada, Pamela J. , Moegling, Michelle , Anderson, Ingrid , Tay, Khoon‐Yen , Scherzer, Daniel , Vora, Samreen , Gaither, Stacy , Fenster, Daniel, Jones, Derick D. , Chatfield, Jenny, Knight, Lynda, Berg, Marc , Makharashvili, Ana, Katznelson, Jessica , Mathias, Emily, Lutfi, Riad , Abu‐Sultaneh, Samer , Padlipsky, Patricia, Lee, Jumie , Butler, Lucas, Alander, Sarah W., Bhatnagar, Ambika , Crellin, Jason, Mannenbach, Mark, Jones, Derick, Sessa, Anna, Lavoie, Meghan, Dudas, Robert Arthur , Aebersold, Michelle , Burns, Brian, Thomas, Anita Anne , Jafri, Farrukh Nadeem , Abulebda, Kamal

Mayo Clinic

Pediatrics | July 7, 2023 | Volume: 152 | Issue: 2 | Pages: No page available

10.1542/peds.2022-060790 | PMID 37416979 Get It

OBJECTIVES To describe the quality of pediatric resuscitative care in general emergency departments (GEDs) and to determine hospital-level factors associated with higher quality. METHODS Prospective observational study of resuscitative care provided to 3 in situ simulated patients (infant seizure, infant sepsis, and child cardiac arrest) by interprofessional GED teams. A composite quality score (CQS) was measured and the association of this score with modifiable and nonmodifiable hospital-level factors was explored. RESULTS A median CQS of 62.8 of 100 (interquartile range 50.5–71.1) was noted for 287 resuscitation teams from 175 emergency departments. In the unadjusted analyses, a higher score was associated with the modifiable factor of an affiliation with a pediatric academic medical center (PAMC) and the nonmodifiable factors of higher pediatric volume and location in the Northeast and Midwest. In the adjusted analyses, a higher CQS was associated with modifiable factors of an affiliation with a PAMC and the designation of both a nurse and physician pediatric emergency care coordinator, and nonmodifiable factors of higher pediatric volume and location in the Northeast and Midwest. A weak correlation was noted between quality and pediatric readiness scores. CONCLUSIONS A low quality of pediatric resuscitative care, measured using simulation, was noted across a cohort of GEDs. Hospital factors associated with higher quality included: an affiliation with a PAMC, designation of a pediatric emergency care coordinator, higher pediatric volume, and geographic location. A weak correlation was noted between quality and pediatric readiness scores.
Multidisciplinary Treatment of Merkel Cell Carcinoma of the Extremities: Outcomes and Factors Associated with Poor Survival in Nodal Disease
Broida, Samuel E. , Chen, Xiao T. , Wahlig, Brian D. , Moran, Steven L. , Houdek, Matthew T. , Houdek, Matthew T , Broida, Samuel E

Mayo Clinic

Current Oncology | June 30, 2023 | Volume: 30 | Issue: 7 | Pages: 6246-6254

10.3390/curroncol30070462 | PMID 37504322 Get It

Merkel cell carcinoma (MCC) has a tendency for lymphatic spread and locoregional recurrence, although there is little data examining the risk factors for patients with lymph node-positive extremity lesions. The purpose of the current study was to examine the outcomes and risk factors associated with nodal metastasis in extremity MCC. We retrospectively reviewed the medical record of 120 patients with extremity MCC evaluated at our institution between 1994 and 2021. The mean age of this cohort was 71 years; 33% of patients were female; and 98% were Caucasian. Seventy-eight (65%) patients presented with localized disease. Thirty-seven (31%) patients had stage III disease, and five (4%) patients had stage IV disease. Treatment of primary lesions consisted primarily of margin-negative excision and adjuvant radiotherapy. Nodal metastases were most treated with adjuvant radiation or completion lymph node dissection. Five-year disease-specific survival in our series was 88% for patients with localized disease, 89% for stage IIIa disease, 40% for stage IIIb disease and 42% for stage IV. Factors associated with worse survival included immunosuppression and macroscopic nodal disease. In conclusion, extremity MCC has a low rate of local recurrence when treated with margin-negative excision and adjuvant radiation. However, treatment of nodal metastases remains a challenge with high rates of recurrence and mortality, particularly for patients who are immunosuppressed or who have macroscopic nodal disease.
Robotics in Plastic Surgery: It’s Here
Trotsyuk, Artem A. , Sivaraj, Dharshan , Mittal, Smiti , Chattopadhyay, Arhana , Larson, Madelyn R., Kinney, Brian M. , Nachbar, James, TerKonda, Sarvam P. , Reddy, Sashank , Jeffers, Lynn , Sacks, Justin M. , Gurtner, Geoffrey C. , Henn, Dominic , Barrera, Janos A. , Chen, Kellen , Mermin-Bunnell, Alana M.

Mayo Clinic

Plastic & Reconstructive Surgery | June 29, 2023 | Volume: 152 | Issue: 1 | Pages: 239-249

10.1097/prs.0000000000010270 | PMID 37382921 Get It

Summary: Although robotic surgery has been routinely established in other surgical disciplines, robotic technologies have been less readily adopted in plastic surgery. Despite a strong demand for innovation and cutting-edge technology in plastic surgery, most reconstructive procedures, including microsurgery, have continued to necessitate an open approach. Recent advances in robotics and artificial intelligence, however, are gaining momentum and have shown significant promise to improve patient care in plastic surgery. These next-generation surgical robots have the potential to enable surgeons to perform complex procedures with greater precision, flexibility, and control than previously possible with conventional techniques. Successful integration of robotic technologies into clinical practice in plastic surgery requires achieving key milestones, including implementing appropriate surgical education and garnering patient trust.